ÁÖÁ¦º°°Ë»ö
(current)
Å°¿öµå°Ë»ö
(±¸)µ¥ÀÌÅÍ°Ë»ö
¾÷µ¥ÀÌÆ®Á¤º¸
°ü·Ã»çÀÌÆ®
CÇü°£¿° ȯÀÚ¿¡¼ Æä±×ÀÎÅÍÆä·ÐÄ¡·á ÈÄ ¹ß»ýÇÑ ´Ù¹ß±ÙÀ°¿°
Polymyositis after Pegylated Interferon Therapy for Hepatitis C
´ëÇѽŰæ°úÇÐȸÁö
2014³â 32±Ç 4È£ p.342 ~ p.344
±è½Ã³»
(Kim Shi-Nae) - ÀÎÁ¦´ëÇб³ ÀÇ°ú´ëÇÐ ½Å°æ°úÇб³½Ç
Çѽ¹Î
(Han Seung-Min) - ÀÎÁ¦´ëÇб³ ÀÇ°ú´ëÇÐ ½Å°æ°úÇб³½Ç
¹ÚÁßÇö
(Park Joong-Hyun) - ÀÎÁ¦´ëÇб³ ÀÇ°ú´ëÇÐ ½Å°æ°úÇб³½Ç
±èÁ¤¿¬
(Kim Jeong-Yeon) - ÀÎÁ¦´ëÇб³ ÀÇ°ú´ëÇÐ ½Å°æ°úÇб³½Ç
¹ÚÀçÇö
(Park Jae-Hyeon) - ÀÎÁ¦´ëÇб³ ÀÇ°ú´ëÇÐ ½Å°æ°úÇб³½Ç
Abstract
Å°¿öµå
Hepatitis C, Interferon, Polymyositis
KMID :
0359720140320040342
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
ÁÖÁ¦ÄÚµå
ÁÖÁ¦¸í(Target field)
¿¬±¸´ë»ó(Population)
¿¬±¸Âü¿©(Sample size)
´ë»ó¼ºº°(Gender)
Áúº´Æ¯¼º(Condition Category)
¿¬±¸È¯°æ(Setting)
¿¬±¸¼³°è(Study Design)
¿¬±¸±â°£(Period)
ÁßÀç¹æ¹ý(Intervention Type)
ÁßÀç¸íĪ(Intervention Name)
Å°¿öµå(Keyword)
À¯È¿¼º°á°ú(Recomendation)
¿¬±¸ºñÁö¿ø(Fund Source)
±Ù°Å¼öÁØÆò°¡(Evidence Hierarchy)
ÃâÆdz⵵(Year)
Âü¿©ÀúÀÚ¼ö(Authors)
´ëÇ¥ÀúÀÚ
DOI
KCDÄÚµå
ICD 03
°Ç°º¸ÇèÄÚµå